207 related articles for article (PubMed ID: 36271053)
1. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
Wang Z; Wang S; Qin J; Zhang X; Lu G; Liu H; Guo H; Wu L; Shender VO; Shao C; Kong B; Liu Z
Nat Commun; 2022 Oct; 13(1):6246. PubMed ID: 36271053
[TBL] [Abstract][Full Text] [Related]
2. Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.
Liu X; Zhang J; Wang Z; Yan M; Xu M; Li G; Shender V; Wei JJ; Li J; Shao C; Zhang S; Kong B; Song K; Liu Z
Adv Sci (Weinh); 2024 Apr; 11(15):e2306229. PubMed ID: 38342602
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Kontos CK; Scorilas A
Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
[TBL] [Abstract][Full Text] [Related]
4. The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
Li Y; Chen Z; Peng J; Yuan C; Yan S; Yang N; Li P; Kong B
Oncogene; 2023 Jul; 42(31):2386-2401. PubMed ID: 37391593
[TBL] [Abstract][Full Text] [Related]
5. Context dependent splicing functions of Bud31/Ycr063w define its role in budding and cell cycle progression.
Saha D; Banerjee S; Bashir S; Vijayraghavan U
Biochem Biophys Res Commun; 2012 Aug; 424(3):579-85. PubMed ID: 22789856
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.
Adamopoulos PG; Kontos CK; Tsiakanikas P; Scorilas A
Cancer Lett; 2016 Apr; 373(1):119-129. PubMed ID: 26797417
[TBL] [Abstract][Full Text] [Related]
7. Bud31-mediated alternative splicing is required for spermatogonial stem cell self-renewal and differentiation.
Qin J; Huang T; Wang Z; Zhang X; Wang J; Dang Q; Cui D; Wang X; Zhai Y; Zhao L; Lu G; Shao C; Li S; Liu H; Liu Z
Cell Death Differ; 2023 Jan; 30(1):184-194. PubMed ID: 36114296
[TBL] [Abstract][Full Text] [Related]
8. Saccharomyces cerevisiae NineTeen complex (NTC)-associated factor Bud31/Ycr063w assembles on precatalytic spliceosomes and improves first and second step pre-mRNA splicing efficiency.
Saha D; Khandelia P; O'Keefe RT; Vijayraghavan U
J Biol Chem; 2012 Feb; 287(8):5390-9. PubMed ID: 22215661
[TBL] [Abstract][Full Text] [Related]
9.
Choudhry M; Gamallat Y; Khosh Kish E; Seyedi S; Gotto G; Ghosh S; Bismar TA
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047027
[TBL] [Abstract][Full Text] [Related]
10. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.
Maurin M; Ranjouri M; Megino-Luque C; Newberg JY; Du D; Martin K; Miner RE; Prater MS; Wee DKB; Centeno B; Pruett-Miller SM; Stewart P; Fleming JB; Yu X; Bravo-Cordero JJ; Guccione E; Black MA; Mann KM
Nat Commun; 2023 Dec; 14(1):8444. PubMed ID: 38114498
[TBL] [Abstract][Full Text] [Related]
11. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A
Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122
[TBL] [Abstract][Full Text] [Related]
12. RNA splicing: a dual-edged sword for hepatocellular carcinoma.
Kashyap A; Tripathi G; Tripathi A; Rao R; Kashyap M; Bhat A; Kumar D; Rajhans A; Kumar P; Chandrashekar DS; Mahmood R; Husain A; Zayed H; Bharti AC; Kashyap MK
Med Oncol; 2022 Aug; 39(11):173. PubMed ID: 35972700
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
He X; Ee PL; Coon JS; Beck WT
Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
[TBL] [Abstract][Full Text] [Related]
15. BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer.
Kladi-Skandali A; Sideris DC; Scorilas A
Clin Chem Lab Med; 2018 Dec; 57(2):276-287. PubMed ID: 30325729
[TBL] [Abstract][Full Text] [Related]
16. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
Wang X; Yan L; Guo J; Jia R
Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
[TBL] [Abstract][Full Text] [Related]
17. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
18. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
Mercatante DR; Bortner CD; Cidlowski JA; Kole R
J Biol Chem; 2001 May; 276(19):16411-7. PubMed ID: 11278482
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB.
Khoo B; Roca X; Chew SL; Krainer AR
BMC Mol Biol; 2007 Jan; 8():3. PubMed ID: 17233885
[TBL] [Abstract][Full Text] [Related]
20. GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.
Chou CH; Chou AK; Lin CC; Chen WJ; Wei CC; Yang MC; Hsu CM; Lung FW; Loh JK; Howng SL; Hong YR
Cell Cycle; 2012 Feb; 11(3):532-42. PubMed ID: 22262180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
